Procaps Roe from 2010 to 2024

PROC Stock  USD 1.27  0.35  38.04%   
Procaps Group's ROE is decreasing over the years with slightly volatile fluctuation. Overall, ROE is projected to go to -49.39 this year. During the period from 2010 to 2024 Procaps Group ROE annual values regression line had coefficient of variation of (213.77) and r-squared of  0.47. View All Fundamentals
 
ROE  
First Reported
2010-12-31
Previous Quarter
(51.99)
Current Value
(49.39)
Quarterly Volatility
20.40161511
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Procaps Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procaps Group's main balance sheet or income statement drivers, such as Tax Provision of 12.7 M, Depreciation And Amortization of 13 M or Interest Expense of 39 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or Days Sales Outstanding of 87.22. Procaps financial statements analysis is a perfect complement when working with Procaps Group Valuation or Volatility modules.
  
Check out the analysis of Procaps Group Correlation against competitors.

Latest Procaps Group's Roe Growth Pattern

Below is the plot of the Roe of Procaps Group SA over the last few years. It is Procaps Group's ROE historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procaps Group's overall financial position and show how it may be relating to other accounts over time.
Roe10 Years Trend
Slightly volatile
   Roe   
       Timeline  

Procaps Roe Regression Statistics

Arithmetic Mean(9.54)
Coefficient Of Variation(213.77)
Mean Deviation15.73
Median0.07
Standard Deviation20.40
Sample Variance416.23
Range54.6869
R-Value(0.68)
Mean Square Error238.13
R-Squared0.47
Significance0
Slope(3.12)
Total Sum of Squares5,827

Procaps Roe History

2024 -49.39
2023 -51.99
2022 -45.21
2021 2.7
2020 0.0409

About Procaps Group Financial Statements

Procaps Group stakeholders use historical fundamental indicators, such as Procaps Group's Roe, to determine how well the company is positioned to perform in the future. Although Procaps Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Procaps Group's assets and liabilities are reflected in the revenues and expenses on Procaps Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Procaps Group SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
ROE(51.99)(49.39)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Procaps Group SA is a strong investment it is important to analyze Procaps Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Procaps Group's future performance. For an informed investment choice regarding Procaps Stock, refer to the following important reports:
Check out the analysis of Procaps Group Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procaps Group. If investors know Procaps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procaps Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.64)
Earnings Share
0.51
Revenue Per Share
4.097
Quarterly Revenue Growth
0.073
Return On Assets
0.0628
The market value of Procaps Group SA is measured differently than its book value, which is the value of Procaps that is recorded on the company's balance sheet. Investors also form their own opinion of Procaps Group's value that differs from its market value or its book value, called intrinsic value, which is Procaps Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procaps Group's market value can be influenced by many factors that don't directly affect Procaps Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procaps Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procaps Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procaps Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.